GleamWall
中文EN

AMIX Autonomix Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1617867 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY29.4%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-176.0%
ROA-146.1%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets15.3%
Debt / equity0.00x
Current ratio6.52x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.02x
Accruals ratio2.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue$0$0
R&D expense$7.14M$4.72M
SG&A expense$9.89M$6.86M
Operating income-$17.03M-$11.59M
Interest expense$0$176,000
Pretax income-$16.71M-$11.41M
Income tax$0$0
Net income-$16.71M-$11.41M
EBITDA-$17.02M-$11.40M
EPS (basic)-2.32-6.46
EPS (diluted)——
Balance sheet
Cash & equivalents$7.00M$9.14M
Current assets$7.58M$9.61M
PP&E, net$19,000$21,000
Total assets$7.60M$9.81M
Current liabilities$1.71M$1.71M
Total liabilities$1.71M$1.71M
Shareholders' equity$5.89M$8.10M
Shares outstanding542,3122.50M
Cash flow statement
Operating cash flow-$12.28M-$8.26M
Capital expenditure$10,000$14,000
Free cash flow-$12.29M-$8.27M
Investing cash flow-$10,000-$14,000
Financing cash flow$10.16M$8.80M
Depreciation & amortization$12,000$183,000
Stock-based compensation$529,000$1.63M

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.